Your Search for 'Singapore Pharmaceuticals and Healthcare Report Q1 2011' returned 52 results - Page 1 of 3

• Singapore Pharmaceuticals and Healthcare Report Q1 2013

  EURO€ 891.00USD$ 1,160.00GBP£ 750.00AUD$ 1,134.00JPY¥ 114,506.00SEK 7 615,00CHF 1'093.00CAD$ 1,182.00 Business Monitor International, Jan 2013 , Pages: 112
  Singapore Pharmaceuticals and Healthcare Report Q1 2013 BMI View Singapore will be of moderate attractiveness to investors given its small pharmaceutical market size, despite the growing demands for ...

• Singapore Pharmaceuticals and Healthcare Report Q2 2013

  EURO€ 891.00USD$ 1,160.00GBP£ 750.00AUD$ 1,134.00JPY¥ 114,506.00SEK 7 615,00CHF 1'093.00CAD$ 1,182.00 Business Monitor International, Feb 2013 , Pages: 114
  Singapore Pharmaceuticals and Healthcare Report Q2 2013 BMI View: The pharmaceutical market in Singapore is small, but supported by an increasingly ageing population and the corresponding rise in ...

• Singapore Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Dec 2011 , Pages: 92
  Singapore Pharmaceuticals and Healthcare Report Q1 2012 Business Monitor International's Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ...

• Singapore Pharmaceuticals and Healthcare Report Q3 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jul 2012 , Pages: 104
  Singapore Pharmaceuticals and Healthcare Report Q3 2012 The Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Singapore Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 95
  Singapore Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's (BMI) Singapore Pharmaceuticals and Healthcare Report (Q4 2011) provides industry professionals and ...

• Singapore Pharmaceuticals and Healthcare Report Q3 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jun 2011 , Pages: 92
  Singapore Pharmaceuticals and Healthcare Report Q3 2011 The Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• Life Science & Chemical Instrumentation Market (2011 – 2016) (Spectroscopy, Chromatography, Dna Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others) Global Trends, End User & Competitive Analysis

  EURO€ 3,574.00USD$ 4,650.00GBP£ 3,007.00AUD$ 4,548.00JPY¥ 459,108.00SEK 30 531,00CHF 4'383.00CAD$ 4,738.00 Markets and Markets, Feb 2012 , Pages: 391
  & Pharmaceuticals 5.10.4 Others 6 Geographical Analysis 6.1 Introduction 6.2 U.S. 6.3 Europe 6.4 Asia 6.4.1 Singapore 6.5 Rest Of The World 7 Competitive Landscape 7.1 Chromatography 7.1.1 New ...

• Pharmaceuticals - Global Outlook

  EURO€ 1,766.00USD$ 1,995.00GBP£ 1,177.00AUD$ 2,759.00JPY¥ 239,238.00SEK 15 694,00CHF 2'627.00CAD$ 2,559.00 Global Industry Analysts, Inc, Jan 2012 , Pages: 443
  curtail increasing healthcare expenditure is beginning to hurt the prescription pharmaceuticals sector in some markets, a trend that is expected to continue in the near future, as more and more countries ...

• China Pharmaceuticals and Healthcare Report Q3 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jul 2012 , Pages: 114
  China Pharmaceuticals and Healthcare Report Q3 2012 The China Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...

• Cambodia Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Oct 2011 , Pages: 54
  Cambodia Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's Cambodia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ...

• Singapore Pharmaceuticals and Healthcare Report Q3 2009

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jun 2009 , Pages: 94
  Singapore Pharmaceuticals and Healthcare Report Q3 2009 Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ...

• PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry

  EURO€ 2,302.00USD$ 2,995.00GBP£ 1,937.00AUD$ 2,929.00JPY¥ 295,705.00SEK 19 665,00CHF 2'823.00CAD$ 3,052.00 GlobalData, Apr 2013 , Pages: 80
  , Deal Summary 2012 1.2 List of Figures Figure 1: Lipitor Sales WW vs. US, 4Q11–4Q12 Figure 2: Pharmaceuticals and Healthcare, Number of Deals and Deal Values (US $m), Globally from September 2012 ...

• Puerto Rico Pharmaceuticals and Healthcare Report Q1 2013

  EURO€ 891.00USD$ 1,160.00GBP£ 750.00AUD$ 1,134.00JPY¥ 114,506.00SEK 7 615,00CHF 1'093.00CAD$ 1,182.00 Business Monitor International, Jan 2013 , Pages: 85
  Puerto Rico Pharmaceuticals and Healthcare Report Q1 2013 BMI View: The outcome of the upcoming elections is expected to assist in shaping the development of Puerto Rico's healthcare and ...

• Hong Kong Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Dec 2011 , Pages: 91
  Hong Kong Pharmaceuticals and Healthcare Report Q1 2012 Business Monitor International's Hong Kong Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ...

• Taiwan Pharmaceuticals and Healthcare Report Q1 2013

  EURO€ 891.00USD$ 1,160.00GBP£ 750.00AUD$ 1,134.00JPY¥ 114,506.00SEK 7 615,00CHF 1'093.00CAD$ 1,182.00 Business Monitor International, Dec 2012 , Pages: 108
  Taiwan Pharmaceuticals and Healthcare Report Q1 2013 BMI View: We continue to view Taiwan as a challenging market for multinationals, mostly on account of the difficult pricing and reimbursement ...

• Hong Kong Pharmaceuticals and Healthcare Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 92
  Hong Kong Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's (BMI) Hong Kong Pharmaceuticals and Healthcare Report (Q4 2011) provides industry professionals and ...

• Indonesia Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Feb 2012 , Pages: 97
  Indonesia Pharmaceuticals and Healthcare Report Q1 2012 Business Monitor International's Indonesia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ...

• Vietnam Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Jan 2012 , Pages: 101
  Vietnam Pharmaceuticals and Healthcare Report Q1 2012 Business Monitor International's Vietnam Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ...

• Taiwan Pharmaceuticals and Healthcare Report Q4 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Aug 2012 , Pages: 98
  Taiwan Pharmaceuticals and Healthcare Report Q4 2012 The Taiwan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...

• Taiwan Pharmaceuticals and Healthcare Report Q1 2012

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2011 , Pages: 112
  Taiwan Pharmaceuticals and Healthcare Report Q1 2012 Business Monitor International's Taiwan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ...